Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
DOVA PHARMACEUTICALS, INC.
Jurisdiction of Incorporation/Organization
DELAWARE
Year of Incorporation/Organization
2016
Previous Name(s)
- DOVA PHARMACEUTICALS, LLC
- PBM AKX HOLDINGS, LLC
Item 2 Issuer Principal Place of Business and Contact Information
200 GARRETT STREET
SUITE S
CHARLOTTESVILLE, VA 22902
Phone Number:
subscription required
Item 3. Related Persons
Name
PAUL B. MANNING
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
JOHN A. STALFORT
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
JAMES C. REEBALS
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
EUGENE R. SCAVOLA
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
DAMIAN DEGOA
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
RUSSELL T. SCHUNDLER
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- PROMOTER
Clarification of Response
Item 3. Related Persons
Name
HOSSEIN EKRAMI
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
PBM CAPITAL INVESTMENTS LLC
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BKB GROWTH INVESTMENTS, LLC
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
09/19/2016
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
2500000
Item 13. Offering and Sales Amounts
Total Offering Amount
40000000
Total Amount Sold
10000000
Total Remaining to be Sold
30000000
Clarification of Response
THE ISSUER'S BOARD MAY HAVE ONE OR MORE CLOSINGS AT ANY TIME AND FROM TIME TO TIME AFTER RECEIVING INVESTMENTS TOTALING $10,000,000. THE ISSUER'S BOARD MAY ALSO ACCEPT LESS THAN THE STATED MINIMUM INVESTMENT AMOUNT OF $2,500,000 IN ITS DISCRETION.
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
1
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
0.0 Is an estimate
Finders' Fees
0.0 Is an estimate
Clarification of Response
THE ISSUER MAY IN THE FUTURE RETAIN A BROKER IN CONNECTION WITH THE OFFERING BUT HAS NOT YET DONE SO.
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
600000.0 Is an estimate
Clarification of Response
Signature and Submission
Issuer Name
DOVA PHARMACEUTICALS, INC.
Issuer Signature
/RUSSELL T. SCHUNDLER/
Signer Name
RUSSELL T. SCHUNDLER
Signer Title
SECRETARY
Signature Date
09/23/2016